Loading...
Biologic Therapies for Giant Cell Arteritis
Glucocorticoids have been the mainstay of treatment in giant cell arteritis (GCA) for the past 70 years. Conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) have largely failed to show significant clinical efficacy or reduction of the glucocorticoid burden in GCA. Tocilizumab is...
Na minha lista:
| Udgivet i: | Biologics |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797292/ https://ncbi.nlm.nih.gov/pubmed/33442231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S229662 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|